Pain Management After Elective Shoulder Surgery

AUVA Traumazentrum Vienna Site UKH Meidling

Status and phase: Completed; Phase 4

Conditions: Postoperative Pain

Treatments: Drug: Hydromorphone Hcl 4Mg Tab; Drug: Piritramide 15mg s.c.

Study type: Interventional

Funder types: Other

Identifiers

NCT03541759

5/18-Anesthesiology

Details and patient eligibility

About

Postoperative pain management plays an important role in elective shoulder surgery. The aim of this randomized quantitative study is to compare two frequently used postoperative pain regimes (hydromorphone versus piritramide) regarding onset and duration after the effectiveness of the single-shot interscalene block has diminished.

Enrollment: 48 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• all patients undergoing elective shoulder surgery with a single-shot interscalene plexus brachialis block in addition to general anesthesia
• patients aged 18-99 years
• patients being capable of giving an informed consent to participation in this study

Exclusion criteria

• patients aged below 18 years
• patients with decompensated liver, heart or renal insufficiency
• patients with any kind of lung disease
• patients with a chronic pain syndrome
• patients with a previous pain medication with more than 3 drugs over more than 3 months

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

48 participants in 2 patient groups

Hydromorphone

Active Comparator group

Description:

Hydromorphone Hcl 4 milligram (mg) Tab 2 times after surgery as basic medication. Hydromorphone Hcl 2.6mg maximum 2 per 24h when numeric rating scale (NRS) \> 5.

Treatment:

Drug: Hydromorphone Hcl 4Mg Tab

Piritramide

Active Comparator group

Description:

Piritramide 15mg s.c. 2 times after surgery as basic medication. Piritramide 7.5mg s.c. maximum 2 per 24h when numeric rating scale (NRS) \> 5.

Treatment:

Drug: Piritramide 15mg s.c.